{"id":218739,"date":"2025-12-10T15:16:01","date_gmt":"2025-12-10T20:16:01","guid":{"rendered":"https:\/\/www.aclu.org\/?post_type=press_release&#038;p=218739"},"modified":"2025-12-10T15:16:01","modified_gmt":"2025-12-10T20:16:01","slug":"aclu-comment-on-new-lawsuit-seeking-to-ban-most-common-abortion-medication-nationwide","status":"publish","type":"press_release","link":"https:\/\/www.aclu.org\/press-releases\/aclu-comment-on-new-lawsuit-seeking-to-ban-most-common-abortion-medication-nationwide","title":{"rendered":"ACLU Comment on New Lawsuit Seeking to Ban Most Common Abortion Medication Nationwide"},"menu_order":0,"template":"","class_list":["post-218739","press_release","type-press_release","status-publish","hentry"],"acf":{"subheading":"Access to mifepristone is under serious threat from both the courts and the Trump administration ","date_and_time":"2025-12-10 15:14:13","featured_image":"","show_on_press_releases_landing_page":true,"components":[{"acf_fc_layout":"text","text":{"text":"WASHINGTON \u2014 Today, the states of Florida and Texas filed a new <a href=\"https:\/\/www.bloomberglaw.com\/public\/desktop\/document\/StateofFloridaetalvUSFoodandDrugAdministrationetalDocketNo725cv00?doc_id=X6JTF8JOLA39CABRMDEJ6A6D19B\">lawsuit<\/a> in federal court in Texas seeking to end all nationwide access to mifepristone, a safe and effective medication used in <a href=\"https:\/\/www.guttmacher.org\/2024\/03\/medication-abortion-accounted-63-all-us-abortions-2023-increase-53-2020\">two-thirds<\/a> of U.S. abortions and as part of a gold-standard regimen for miscarriage care. The new lawsuit, <em>Florida v. FDA<\/em>, seeks to undo every FDA policy decision on mifepristone going back to the medication\u2019s original approval 25 years ago.\r\n\r\n<em>Florida v. FDA<\/em> is one of three pending federal lawsuits attacking mifepristone. The other two, <em>Missouri v. FDA<\/em> and <em>Louisiana v. FDA<\/em>, seek to severely restrict medication abortion access nationwide by, among other things, banning the use of telemedicine and pharmacies for mifepristone \u2014 forcing every patient to travel to pick up their prescription in person at a health center, which may be hundreds of miles away. Recent <a href=\"https:\/\/societyfp.org\/research\/wecount\/wecount-june-2025-data\/\">data<\/a> show that, by June 2025, more than 1 in 4 U.S. abortions were provided via telemedicine using mifepristone.\r\n\r\n\u201cThese lawsuits have nothing to do with the safety of this medication and everything to do with making it harder for people to get an abortion,\u201d said <strong>Julia Kaye, senior staff attorney with the ACLU\u2019s Reproductive Freedom Project<\/strong>. \u201cPoliticians in Texas and Florida are asking for a nationwide ban on a safe and effective medication that millions of Americans have used since the FDA first approved it 25 years ago. Anyone who believes that our access to essential medicines should be based on science, not political ideology, should be disgusted by these legal attacks.\u201d\r\n\r\nMifepristone\u2019s excellent safety record has been confirmed by <a href=\"https:\/\/www.nytimes.com\/interactive\/2023\/04\/01\/health\/abortion-pill-safety.html\">more than a hundred<\/a> peer-reviewed studies and <a href=\"https:\/\/www.supremecourt.gov\/DocketPDF\/23\/23-235\/284910\/20231012165311306_Amicus%20Brief%20of%20American%20College%20of%20Obstetricians%20and%20Gynecologists%20et%20al..pdf\">leading medical authorities<\/a> like the American Medical Association and the American College of Obstetricians and Gynecologists.\r\n\r\nFlorida and Texas\u2019s new lawsuit comes as the Trump administration appears to be gearing up to make it even harder for people to access the medication nationwide. Earlier this year, the Trump administration announced that the FDA is conducting a new review of its mifepristone regulations prompted by a report from a Project 2025 sponsor that purposefully distorts the safety record of medication abortion. This paper is a six-page, non-peer-reviewed document that has been <a href=\"https:\/\/law.ucla.edu\/sites\/default\/files\/PDFs\/Center_on_Reproductive_Health\/Reproductive%20Health%20Researchers%20Comment%20Letter%20to%20FDA%208.27.25.pdf\">denounced by more than 260 expert researchers<\/a> for its lack of transparency and gravely flawed methodology. Nevertheless, in a <a href=\"https:\/\/www.thegatewaypundit.com\/2025\/09\/trump-admin-rfk-jr-moves-address-assess-safety\/\">letter<\/a> to anti-abortion state attorneys general on Sept. 19, 2025, Secretary Kennedy doubled down on the publication\u2019s importance, citing this propaganda as a \u201crecent stud[y] raising concerns about the safety of mifepristone as currently administered.\u201d Secretary Kennedy also <a href=\"https:\/\/www.help.senate.gov\/hearings\/hearing-on-fiscal-year-2026-department-of-health-and-human-services-budget\">stated<\/a> that the FDA\u2019s \u201cpolicy changes will ultimately go through the White House, through President Trump.\u201d\r\n\r\nPolling <a href=\"https:\/\/www.aclu.org\/documents\/2025-mab-polling-memo\">consistently<\/a> shows that American voters support access to abortion, including medication abortion via mail and telemedicine. At the same time, voters worry that access to abortion remains under threat: a  <a href=\"https:\/\/navigatorresearch.org\/three-years-after-the-overturning-of-roe\/\">June 2025 poll by Navigator Research<\/a> showed that nearly seven in ten voters believe abortion will be harder to access in the next five years."}}],"drupal_node_id":"","email":"media@aclu.org","phone":"(212) 549-2666","address":{"address_1":"125 Broad Street","address_2":"18th Floor","city":"New York","state":"NY","zip_code":10004,"country":"United States"},"pgp_public_key":"","issues":[46316,46701],"press_releases_related_to_cases":"","spokesperson":[1818],"related_affiliates":"","related_content_documents":"","related_content_publications":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>American Civil Liberties Union<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ACLU Comment on New Lawsuit Seeking to Ban Most Common Abortion Medication Nationwide | American Civil Liberties Union\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.aclu.org\/press-releases\/aclu-comment-on-new-lawsuit-seeking-to-ban-most-common-abortion-medication-nationwide\" \/>\n<meta property=\"og:site_name\" content=\"American Civil Liberties Union\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@aclu\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.aclu.org\/press-releases\/aclu-comment-on-new-lawsuit-seeking-to-ban-most-common-abortion-medication-nationwide\",\"url\":\"https:\/\/www.aclu.org\/press-releases\/aclu-comment-on-new-lawsuit-seeking-to-ban-most-common-abortion-medication-nationwide\",\"name\":\"ACLU Comment on New Lawsuit Seeking to Ban Most Common Abortion Medication Nationwide | American Civil Liberties Union\",\"isPartOf\":{\"@id\":\"https:\/\/www.aclu.org\/#website\"},\"datePublished\":\"2025-12-10T20:16:01+00:00\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.aclu.org\/press-releases\/aclu-comment-on-new-lawsuit-seeking-to-ban-most-common-abortion-medication-nationwide\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.aclu.org\/#website\",\"url\":\"https:\/\/www.aclu.org\/\",\"name\":\"American Civil Liberties Union\",\"description\":\"The ACLU dares to create a more perfect union \u2014 beyond one person, party, or side. Our mission is to realize this promise of the United States Constitution for all and expand the reach of its guarantees.\",\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"American Civil Liberties Union","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"ACLU Comment on New Lawsuit Seeking to Ban Most Common Abortion Medication Nationwide | American Civil Liberties Union","og_url":"https:\/\/www.aclu.org\/press-releases\/aclu-comment-on-new-lawsuit-seeking-to-ban-most-common-abortion-medication-nationwide","og_site_name":"American Civil Liberties Union","twitter_card":"summary_large_image","twitter_site":"@aclu","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.aclu.org\/press-releases\/aclu-comment-on-new-lawsuit-seeking-to-ban-most-common-abortion-medication-nationwide","url":"https:\/\/www.aclu.org\/press-releases\/aclu-comment-on-new-lawsuit-seeking-to-ban-most-common-abortion-medication-nationwide","name":"ACLU Comment on New Lawsuit Seeking to Ban Most Common Abortion Medication Nationwide | American Civil Liberties Union","isPartOf":{"@id":"https:\/\/www.aclu.org\/#website"},"datePublished":"2025-12-10T20:16:01+00:00","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.aclu.org\/press-releases\/aclu-comment-on-new-lawsuit-seeking-to-ban-most-common-abortion-medication-nationwide"]}]},{"@type":"WebSite","@id":"https:\/\/www.aclu.org\/#website","url":"https:\/\/www.aclu.org\/","name":"American Civil Liberties Union","description":"The ACLU dares to create a more perfect union \u2014 beyond one person, party, or side. Our mission is to realize this promise of the United States Constitution for all and expand the reach of its guarantees.","inLanguage":"en-US"}]}},"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"American Civil Liberties Union","distributor_original_site_url":"https:\/\/www.aclu.org","push-errors":false,"_links":{"self":[{"href":"https:\/\/www.aclu.org\/wp-json\/wp\/v2\/press_release\/218739","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aclu.org\/wp-json\/wp\/v2\/press_release"}],"about":[{"href":"https:\/\/www.aclu.org\/wp-json\/wp\/v2\/types\/press_release"}],"version-history":[{"count":2,"href":"https:\/\/www.aclu.org\/wp-json\/wp\/v2\/press_release\/218739\/revisions"}],"predecessor-version":[{"id":218741,"href":"https:\/\/www.aclu.org\/wp-json\/wp\/v2\/press_release\/218739\/revisions\/218741"}],"acf:post":[{"embeddable":true,"href":"https:\/\/www.aclu.org\/wp-json\/wp\/v2\/bios\/1818"},{"embeddable":true,"href":"https:\/\/www.aclu.org\/wp-json\/wp\/v2\/issue\/46701"},{"embeddable":true,"href":"https:\/\/www.aclu.org\/wp-json\/wp\/v2\/issue\/46316"}],"wp:attachment":[{"href":"https:\/\/www.aclu.org\/wp-json\/wp\/v2\/media?parent=218739"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}